Revealing the mutually enhanced mechanism of necroptosis and immunotherapy induced by defect engineering and piezoelectric effect
Y Du, J Yang, F He, X Zhao, J Zhou, P Zang… - Advanced …, 2024 - Wiley Online Library
Owing to low immunogenicity‐induced immune escape and short‐term circulating immune
responses, the efficiency of immunotherapy is unsatisfactory. Therefore, triggering …
responses, the efficiency of immunotherapy is unsatisfactory. Therefore, triggering …
Light‐responsive inorganic biomaterials for biomedical applications
HP Lee, AK Gaharwar - Advanced science, 2020 - Wiley Online Library
Light‐responsive inorganic biomaterials are an emerging class of materials used for
developing noninvasive, noncontact, precise, and controllable medical devices in a wide …
developing noninvasive, noncontact, precise, and controllable medical devices in a wide …
Second near‐infrared light‐activatable polymeric nanoantagonist for photothermal immunometabolic cancer therapy
Immunometabolic modulation offers new opportunities to treat cancers as it is highly
associated with cancer progression and immunosuppressive microenvironment. However …
associated with cancer progression and immunosuppressive microenvironment. However …
MnOx Nanospikes as Nanoadjuvants and Immunogenic Cell Death Drugs with Enhanced Antitumor Immunity and Antimetastatic Effect
B Ding, P Zheng, F Jiang, Y Zhao… - Angewandte Chemie …, 2020 - Wiley Online Library
Despite the widespread applications of manganese oxide nanomaterials (MONs) in
biomedicine, the intrinsic immunogenicity of MONs is still unclear. MnOx nanospikes (NSs) …
biomedicine, the intrinsic immunogenicity of MONs is still unclear. MnOx nanospikes (NSs) …
Reactive oxygen species-powered cancer immunotherapy: Current status and challenges
M He, M Wang, T Xu, M Zhang, H Dai, C Wang… - Journal of Controlled …, 2023 - Elsevier
Reactive oxygen species (ROS) are crucial signaling molecules that can arouse immune
system. In recent decades, ROS has emerged as a unique therapeutic strategy for malignant …
system. In recent decades, ROS has emerged as a unique therapeutic strategy for malignant …
Engineered nanoparticles for cancer vaccination and immunotherapy
Conspectus The immune system has evolved over time to protect the host from foreign
microorganisms. Activation of the immune system is predicated on a distinction between self …
microorganisms. Activation of the immune system is predicated on a distinction between self …
A mesoporous nanoenzyme derived from metal–organic frameworks with endogenous oxygen generation to alleviate tumor hypoxia for significantly enhanced …
Tumor hypoxia compromises the therapeutic efficiency of photodynamic therapy (PDT) as
the local oxygen concentration plays an important role in the generation of cytotoxic singlet …
the local oxygen concentration plays an important role in the generation of cytotoxic singlet …
Na2S2O8 Nanoparticles Trigger Antitumor Immunotherapy through Reactive Oxygen Species Storm and Surge of Tumor Osmolarity
Although more attention has been attracted to the therapy based on reactive oxygen species
(ROS) for tumor therapy in recent years, such as photodynamic therapy and chemodynamic …
(ROS) for tumor therapy in recent years, such as photodynamic therapy and chemodynamic …
Photodynamic therapy: photosensitizers and nanostructures
A Escudero, C Carrillo-Carrión… - Materials Chemistry …, 2021 - pubs.rsc.org
The reactions of some structures to different external stimuli can be used for therapeutic
purposes. In particular, in photodynamic therapy (PDT), a light-sensitive compound or …
purposes. In particular, in photodynamic therapy (PDT), a light-sensitive compound or …
Electromagnetic nanomedicines for combinational cancer immunotherapy
J Li, Y Luo, K Pu - Angewandte Chemie International Edition, 2021 - Wiley Online Library
Immunotherapy that harnesses the power of the immune system to eliminate malignant cells
has offered an effective approach for cancer treatment. However, limited patient response …
has offered an effective approach for cancer treatment. However, limited patient response …